Document is current
Any future updates will be listed below
-
Authors
Pérez-González, Fabián https://orcid.org/0000-0003-1515-8700
Abusamak, Mohammad https://orcid.org/0000-0002-0955-0055
Sáez-Alcaide, Luis Miguel https://orcid.org/0000-0002-1580-2335
García-Denche, Jesus Torres https://orcid.org/0000-0002-8310-9209
Marino, Faleh Ahmad Tamimi https://orcid.org/0000-0002-4618-8374
-
Funding
Funding for this research was provided by:
Universidad Complutense de Madrid
- License Information
-
More Information
Article History
Received: 4 April 2022
Accepted: 26 July 2022
First Online: 3 August 2022
Declarations
:
: The study was evaluated and approved by the Research Ethics Committee at the San Carlos Clinical Hospital of Madrid, Spain (Trial registration code CEIC 19/216-R_M_BNI.) and the <i>Agencia Española del Medicamento y Productos Sanitarios</i> (AEMPS: <i>Spanish Agency of Drugs and Sanitary Products</i>, EUDRACT number 2019–000736).
: Informed consent was obtained from all participants in writing form.
: The authors declare no competing interests.
